Research news
An international project involving IIBB-CSIC-IDIBAPS aims to study the relationship between hypercaloric diets and liver cancer
The National Cancer Institute of the National Institutes of Health (NIH) will fund a project that aims to decipher the molecular mechanisms by which1
Researchers identify a link between the immune system and survival after breast cancer
Researchers from Hospital Clínic-IDIBAPS have led a study that has found a correlation between anti-tumour immunological activity and longevity in br1
We are looking for a Bioinformatician with a focus on Data Science to support research
The AES25 call includes a section for recruiting bioinformatics technicians to support research at health research institutes. IDIBAPS is seeking can1
New Tablet Shows Promise for the Control and Elimination of Intestinal Worms
The ALIVE clinical trial shows that a tablet combining albendazole and ivermectin is safe and more effective than albendazole alone in treating soil-1
An international study led by a researcher from IDIBAPS-Hospital Clínic Barcelona demonstrates the first significant improvement in the treatment of a subtype of liver cancer in twenty years
The journal The Lancet has published the results of a phase III clinical trial led by Josep Maria Llovet, from IDIBAPS-Hospital Clínic Barcelona. Inv1
Advances made in CAR-T immunotherapy to prevent relapse in multiple myeloma
A team from Clínic-IDIBAPS has introduced a modification to a CAR-T immunotherapy for multiple myeloma that makes it more durable, according to resul1
The Tribute to Marc Grau Charity Concert donates €7,151 to the Clínic Barcelona-IDIBAPS for cancer research
The promoters donated all the proceeds from the concert held on 3 October 2024 to commemorate the 25th anniversary of the death of the Catalan music1
A European project led by IDIBAPS-Hospital Clínic Barcelona studies the efficacy of immunotherapy for childhood melanoma for the first time
Conducted as part of the MELCAYA project, the study demonstrates that anti PD-1 antibody immunotherapy is safe for children and adolescents. Furtherm1
Dr. Miró, nominated elected academic member of the Royal Academy of Medicine of Catalonia
The senior consultant in the Infectious Diseases Service was inducted with a speech about the 40 years he has been working on HIV-AIDS